tiprankstipranks
Jaguar Animal Health Inc. (JAGX)
NASDAQ:JAGX
US Market
JAGX
Jaguar Animal Health
RESEARCH TOOLSreports
Want to see JAGX full AI Analyst Report?

Jaguar Animal Health (JAGX) Ratios

2,367 Followers

Jaguar Animal Health Ratios

JAGX's free cash flow for Q4 2025 was $0.49. For the 2025 fiscal year, JAGX's free cash flow was decreased by $ and operating cash flow was $-3.35. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Mar 24Dec 22
Liquidity Ratios
Current Ratio
 0.50 0.50 1.63 2.00 0.74
Quick Ratio
 0.29 0.29 1.11 1.34 0.50
Cash Ratio
 0.02 0.02 0.41 0.46 0.18
Solvency Ratio
 -1.08 -1.08 -0.77 -0.88 -0.93
Operating Cash Flow Ratio
 -0.58 0.14 -1.49 -2.38 -1.09
Short-Term Operating Cash Flow Coverage
 -0.87 0.21 -2.44 -6.83 -2.08
Net Current Asset Value
$ -36.67M$ -36.67M$ -14.73M$ -17.90M$ -26.49M
Leverage Ratios
Debt-to-Assets Ratio
 1.14 1.14 0.68 0.73 0.73
Debt-to-Equity Ratio
 -2.52 -2.52 5.01 7.48 -53.02
Debt-to-Capital Ratio
 1.66 1.66 0.83 0.88 1.02
Long-Term Debt-to-Capital Ratio
 -6.84 -6.84 0.76 0.86 1.04
Financial Leverage Ratio
 -2.22 -2.22 7.33 10.23 -72.23
Debt Service Coverage Ratio
 -1.66 -1.66 -2.99 -2.91 -1.17
Interest Coverage Ratio
 685.19 685.19 -133.47 -5.37 -2.70
Debt to Market Cap
 91.68 19.58 4.78 30.70 882.47
Interest Debt Per Share
 653.36 18.67 124.80 2.82K 4.07M
Net Debt to EBITDA
 -0.93 -0.93 -0.78 -0.93 -0.88
Profitability Margins
Gross Profit Margin
67.21%67.21%83.27%79.13%83.11%
EBIT Margin
-329.21%-329.21%-333.82%-347.51%-298.36%
EBITDA Margin
-398.82%-398.82%-313.65%-335.62%-279.19%
Operating Profit Margin
-398.82%-398.82%-263.76%-351.31%-287.85%
Pretax Profit Margin
-469.09%-469.09%-335.79%-429.27%-404.78%
Net Profit Margin
-465.42%-465.42%-329.30%-423.11%-396.91%
Continuous Operations Profit Margin
-465.42%-465.42%-335.79%-429.27%-404.78%
Net Income Per EBT
99.22%99.22%98.07%98.57%98.06%
EBT Per EBIT
117.62%117.62%127.31%122.19%140.62%
Return on Assets (ROA)
-139.80%-139.80%-72.05%-81.36%-100.00%
Return on Equity (ROE)
11326.64%309.88%-528.37%-832.49%7222.83%
Return on Capital Employed (ROCE)
1969.46%1969.46%-91.43%-93.24%-201.10%
Return on Invested Capital (ROIC)
-180.03%-180.03%-66.94%-81.66%-102.80%
Return on Tangible Assets
-240.23%-240.23%-110.15%-134.76%-189.72%
Earnings Yield
-10208.84%-2466.70%-517.58%-3535.53%-124532.71%
Efficiency Ratios
Receivables Turnover
 6.78 6.78 7.10 4.47 4.85
Payables Turnover
 0.43 0.43 0.37 0.41 0.35
Inventory Turnover
 0.44 0.44 0.19 0.22 0.29
Fixed Asset Turnover
 7.87 7.87 8.35 5.84 7.05
Asset Turnover
 0.30 0.30 0.22 0.19 0.25
Working Capital Turnover Ratio
 -0.85 -2.95 0.88 3.28 4.84
Cash Conversion Cycle
 45.43 45.43 995.95 836.93 295.15
Days of Sales Outstanding
 53.84 53.84 51.43 81.67 75.31
Days of Inventory Outstanding
 831.65 831.65 1.93K 1.65K 1.27K
Days of Payables Outstanding
 840.06 840.06 986.90 891.27 1.05K
Operating Cycle
 885.49 885.49 1.98K 1.73K 1.35K
Cash Flow Ratios
Operating Cash Flow Per Share
 -356.24 2.49 -99.76 -2.16K -2.83M
Free Cash Flow Per Share
 -356.62 2.48 -100.55 -2.16K -2.97M
CapEx Per Share
 0.38 0.01 0.78 0.00 143.24K
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.01 1.00 1.05
Dividend Paid and CapEx Coverage Ratio
 -949.60 231.92 -127.20 0.00 -19.76
Capital Expenditure Coverage Ratio
 -949.60 231.92 -127.20 0.00 -19.76
Operating Cash Flow Coverage Ratio
 -0.54 0.13 -0.80 -0.90 -0.95
Operating Cash Flow to Sales Ratio
 -2.06 0.50 -2.51 -3.41 -2.77
Free Cash Flow Yield
-4528.25%265.80%-398.21%-2845.72%-91269.93%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 >-0.01 -0.04 -0.19 -0.03 >-0.01
Price-to-Sales (P/S) Ratio
 0.04 0.19 0.64 0.12 <0.01
Price-to-Book (P/B) Ratio
 -0.03 -0.13 1.02 0.24 -0.06
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.02 0.38 -0.25 -0.04 >-0.01
Price-to-Operating Cash Flow Ratio
 -0.02 0.37 -0.25 -0.04 >-0.01
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 <0.01 <0.01 <0.01
Price-to-Fair Value
 -0.03 -0.13 1.02 0.24 -0.06
Enterprise Value Multiple
 -0.94 -0.98 -0.98 -0.97 -0.88
Enterprise Value
 43.16M 44.81M 35.96M 31.79M 29.40M
EV to EBITDA
 -0.94 -0.98 -0.98 -0.97 -0.88
EV to Sales
 3.75 3.89 3.08 3.26 2.46
EV to Free Cash Flow
 -1.82 7.76 -1.21 -0.96 -0.85
EV to Operating Cash Flow
 -1.82 7.73 -1.22 -0.96 -0.89
Tangible Book Value Per Share
 -520.84 -14.88 -40.69 -986.90 -2.03M
Shareholders’ Equity Per Share
 -259.44 -7.41 24.73 321.70 -56.19K
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 0.00 0.00 0.00
Revenue Per Share
 172.73 4.94 39.69 632.97 1.02M
Net Income Per Share
 -803.95 -22.97 -130.69 -2.68K -4.06M
Tax Burden
 0.99 0.99 0.98 0.99 0.98
Interest Burden
 1.42 1.42 1.01 1.24 1.36
Research & Development to Revenue
 2.17 2.17 1.42 1.91 1.48
SG&A to Revenue
 2.42 2.42 2.06 1.70 1.49
Stock-Based Compensation to Revenue
 -0.07 -0.07 0.14 0.22 0.28
Income Quality
 1.54 -0.38 0.75 0.79 0.67
Currency in USD